Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data.
Africa
HIV epidemiology
HIV incidence
HIV prevention
clinical trials
cohort studies
key and vulnerable populations
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
22
12
2020
accepted:
24
08
2021
entrez:
21
10
2021
pubmed:
22
10
2021
medline:
29
10
2021
Statut:
ppublish
Résumé
UNAIDS models suggest HIV incidence is declining in sub-Saharan Africa. The objective of this study was to assess whether modelled trends are supported by empirical evidence. We conducted a systematic review and meta-analysis of adult HIV incidence data from sub-Saharan Africa by searching Embase, Scopus, PubMed and OVID databases and technical reports published between 1 January 2010 and 23 July 2019. We included prospective and cross-sectional studies that directly measured incidence from blood samples. Incidence data were abstracted according to population risk group, geographic location, sex, intervention arm and calendar period. Weighted regression models were used to assess incidence trends across general population studies by sex. We also identified studies reporting greater than or equal to three incidence measurements since 2010 and assessed trends within them. Total 291 studies, including 22 sub-Saharan African countries, met inclusion criteria. Most studies were conducted in South Africa (n = 102), Uganda (n = 46) and Kenya (n = 41); there were 26 countries with no published incidence data, most in western and central Africa. Data were most commonly derived from prospective observational studies (n = 163; 56%) and from geographically defined populations with limited demographic or risk-based enrolment criteria other than age (i.e., general population studies; n = 151; 52%). Across general population studies, average annual incidence declines since 2010 were 0.12/100 person-years (95% CI: 0.06-0.18; p = 0.001) among men and 0.10/100 person-years (95% CI: -0.02-0.22; p = 0.093) among women in eastern Africa, and 0.25/100 person-years (95% CI: 0.17-034; p < 0.0001) among men and 0.42/100 person-years (95% CI: 0.23-0.62; p = 0.0002) among women in southern Africa. In nine of 10 studies with multiple measurements, incidence declined over time, including in two studies of key populations. Across all population risk groups, the highest HIV incidence estimates were observed among men who have sex with men, with rates ranging from 1.0 to 15.4/100 person-years. Within general population studies, incidence was typically higher in women than men with a median female-to-male incidence rate ratio of 1.47 (IQR: 1.11 to 1.83) with evidence of a growing sex disparity over time. Empirical incidence data show the rate of new HIV infections is declining in eastern and southern Africa. However, recent incidence data are non-existent or very limited for many countries and key populations.
Identifiants
pubmed: 34672104
doi: 10.1002/jia2.25818
pmc: PMC8528667
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25818Subventions
Organisme : NIAID NIH HHS
ID : K01 AI125086
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120938
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI128779
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM136577
Pays : United States
Informations de copyright
© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
PLoS Med. 2007 Dec;4(12):e339
pubmed: 18052602
AIDS. 2019 Dec 15;33 Suppl 3:S203-S211
pubmed: 31343430
Lancet HIV. 2019 Oct;6(10):e680-e687
pubmed: 31533894
Lancet HIV. 2018 Nov;5(11):e667-e670
pubmed: 30314745
AIDS. 2015 Nov;29(17):2279-86
pubmed: 26237099
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
Lancet Glob Health. 2020 Sep;8(9):e1132-e1141
pubmed: 32673577
AIDS. 2019 Dec 15;33 Suppl 3:S235-S244
pubmed: 31800403
Science. 2013 Feb 22;339(6122):966-71
pubmed: 23430656
Lancet HIV. 2018 May;5(5):e241-e249
pubmed: 29650451
N Engl J Med. 2017 Nov 30;377(22):2154-2166
pubmed: 29171817
AIDS Rev. 2009 Jul-Sep;11(3):140-56
pubmed: 19654856
Lancet HIV. 2020 Sep;7(9):e629-e640
pubmed: 32771089
N Engl J Med. 2019 Jul 18;381(3):207-218
pubmed: 31314965
Int J Epidemiol. 2018 Apr 1;47(2):537-549
pubmed: 29300904
N Engl J Med. 2019 Jul 18;381(3):230-242
pubmed: 31314967
BMC Pregnancy Childbirth. 2017 Jul 26;17(1):248
pubmed: 28747163
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
Science. 2020 Jul 24;369(6502):366-368
pubmed: 32703860
Open Forum Infect Dis. 2018 Mar 16;5(4):ofy060
pubmed: 29644251
Lancet Infect Dis. 2009 Dec;9(12):747-59
pubmed: 19926035
N Engl J Med. 2019 Jul 18;381(3):219-229
pubmed: 31314966
AIDS. 2017 Apr;31 Suppl 1:S5-S11
pubmed: 28296796
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
Lancet. 2018 Dec 1;392(10162):2334-2335
pubmed: 30527600
Lancet Glob Health. 2019 Nov;7(11):e1521-e1540
pubmed: 31607465
PLoS Med. 2018 Oct 25;15(10):e1002678
pubmed: 30359372